Tech Company Financing Transactions
New Equilibrium Biosciences Funding Round
RA Capital invested in a $10 million funding round for New Equilibrium Biosciences. This venture round was announced by the company on 4/2/2021.
Transaction Overview
Company Name
Announced On
4/2/2021
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
RA Capital (Nathaniel Horwitz)
Proceeds Purpose
The seed will scale up New Equilibrium's R&D facility, expand the team, and accelerate programs targeting IDPs while exploring strategic partnerships.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
700 Main St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
New Equilibrium Biosciences is dedicated to aiding the development of new medicines through cutting edge science and cross--disciplinary collaborations. We leverage our computational--experimental platform to discover lead drug candidates that regulate intrinsically disordered proteins implicated in cancers and neurodegenerative disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Virginia Burger
Co-Founder
Peter Tompa
Browse more venture capital transactions:
Prev: 4/2/2021: Fetch Rewards venture capital transaction
Next: 4/2/2021: StarStock venture capital transaction
Share this article
About Database of VC Transactions
We document funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs